New Combination Therapy for Advanced Small Cell, Lung Cancer Approved in Australia and Singapore
PUBLISHED Monday, April 20, 2026 · cision pr newswire
AI BRIEFING
- ⬤ ZEPZELCA and atezolizumab approved for ES-SCLC in Australia and Singapore
- ⬤ First-line maintenance treatment for extensive-stage small cell lung cancer
- ⬤ New combination therapy offers hope for patients with aggressive lung cancer
ADVERTISEMENT